Waldenstrom's Macroglobulinemia

Show Only Open Trials
1.

Open-label, Phase 1b Study of ACP 196 in Subjects with Waldenstrom Macroglobulinemia

  • Study Status: Open to Enrollment
  • Sponsor: Acerta Pharma
  • Disease Status and/or Stage: Waldenstrom Macroglobulinemia
  • Protocol ID: WCMC IRB #1407015279; Sponsor Protocol #ACE-WM-001; ClinicalTrials.gov #NCT02180724
3.

A Phase Ib/IIa Study of Romidepsin in Combination with Lenalidomide in Adults with Relapsed or Refractory Lymphomas and Myeloma

  • Study Status: Open to Enrollment
  • Sponsor: Memorial Sloan-Kettering Cancer Center
  • Disease Status and/or Stage: Relapsed or Refractory Lymphoma and Multiple Myeloma
4.

Clinical Database and Tissue Repository Collection Project for the Study of Waldenstrom's Macroglobulinemia

  • Study Status: Open to Enrollment
  • Sponsor: Weill Cornell Medical College

Top of page